CRESTOR Film Coated Tablet 40 Milligram
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
25-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ROSUVASTATIN (AS CALCIUM)
Available from:
B & S Healthcare
Dosage:
40 Milligram
Pharmaceutical form:
Film Coated Tablet
Authorization date:
2010-08-13
Summary of Product characteristics
IRISH MEDICINES BOARD ACT 1995, AS AMENDED
MEDICINAL PRODUCTS (CONTROL OF PLACING ON THE MARKET) REGULATIONS, 2007, AS AMENDED
PPA1328/059/004
Case No: 2083385
The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to
B & S HEALTHCARE
UNIT 4, BRADFIELD ROAD, RUISLIP, MIDDLESEX, HA4 0NU, UNITED KINGDOM
an authorisation, subject to the provisions of the said Regulations, in respect of the product
CRESTOR 40 MG FILM-COATED TABLETS
the particulars of which are set out in the attached Schedule. The authorisation is also subject to the general conditions as may be specified in
the said Regulations as listed on the reverse of this document.
This authorisation, unless previously revoked, shall continue in force from 13/08/2010.
Signed on behalf of the Irish Medicines Board this
________________
A person authorised in that behalf by the said Board.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 17/08/2010_
_CRN 2083385_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Crestor 40mg film-coated Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 40mg rosuvastatin (as rosuvastatin calcium).
Each tablet also contains 168.32mg of lactose monohydrate.
For a full list of excipients, see Section 6.1.
3 PHARMACEUTICAL FORM
Film-coated tablet.
_Product imported from UK_: Film-coated tablets, pink, oval and marked with 'ZD4522' on one side and '40' on the
reverse.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
TREATMENT OF HYPERCHOLESTEROLAEMIA
Adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia (type IIa including
heterozygous familial hypercholesterola
Read the complete document
